Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.76 |
| ▸ | CDK1 | P06493 | 1/20 | 0.65 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.61 |
| ▸ | CA9 | Q16790 | 1/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | EGFR | P00533 | 3/20 | 0.55 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2127575 | 0.86 | SMN1; SMN2 (1.00) | SMN1; SMN2CDK1CA12CA1CA2 | |
| SCHEMBL8137802 | 0.86 | SMN1; SMN2 (0.75) | SMN1; SMN2CDK1CA12CA1CA2 | |
| SCHEMBL10334067 | 0.84 | KMT2A (0.71) | SMN1; SMN2CDK1CA12CA1CA2 | |
| SCHEMBL22200953 | 0.84 | SMN1; SMN2 (0.55) | SMN1; SMN2CDK1CA12CA1CA2 | |
| SCHEMBL30621955 | 0.84 | SMN1; SMN2 (0.57) | SMN1; SMN2CDK1CA12CA1CA2 | |
| SCHEMBL925741 | 0.84 | SMN1; SMN2 (0.57) | SMN1; SMN2CDK1CA12CA1CA2 | |
| SCHEMBL23796819 | 0.83 | SMN1; SMN2 (0.58) | SMN1; SMN2CA12CA1CA2CA7 | |
| SCHEMBL30031490 | 0.83 | SMN1; SMN2 (0.58) | SMN1; SMN2CA12CA1CA2CA7 | |
| SCHEMBL18737818 | 0.83 | SMN1; SMN2 (0.66) | SMN1; SMN2CDK1KMT2AMEN1RAB9A | |
| SCHEMBL170522 | 0.82 | KDM4C (0.62) | SMN1; SMN2CA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9929348-B2 | Organic semiconductor composition comprising organic semiconductor material and polymer compound | FUJIFILM CORPORATION (JP) | 2018-03-27 | — | — | US | disclosed |
| US-20160064674-A1 | ORGANIC SEMICONDUCTOR COMOSITION, ORGANIC THIN-FILM TRANSISTOR, ELECTRONIC PAPER, AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2016-03-03 | — | — | US | disclosed |
| US-20160064674-A1 | ORGANIC SEMICONDUCTOR COMOSITION, ORGANIC THIN-FILM TRANSISTOR, ELECTRONIC PAPER, AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2016-03-03 | — | — | US | disclosed |
| US-9224518-B2 | Conductive composition, conductive member, conductive member production method, touch panel, and solar cell | FUJIFILM CORPORATION (JP) | 2015-12-29 | — | — | US | disclosed |
| US-9224518-B2 | Conductive composition, conductive member, conductive member production method, touch panel, and solar cell | FUJIFILM CORPORATION (JP) | 2015-12-29 | — | — | US | disclosed |
| WO-2010042600-A2 | PHOTO-ACTIVATABLE THERAPEUTIC AGENTS AND METHODS OF USING | THE UAB RESEARCH FOUNDATION (US) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010042600-A2 | PHOTO-ACTIVATABLE THERAPEUTIC AGENTS AND METHODS OF USING | THE UAB RESEARCH FOUNDATION (US) | 2010-04-15 | — | — | WO | disclosed |
| US-4933330-A | PSORIASIS | DAK-LABORATORIET (DK) | 1990-06-12 | — | — | US | disclosed |
| EP-0291159-A2 | Aminosalicylic-acid derivatives for the treatment of psoriasis | DAK-LABORATORIET A/S (DK) | 1988-11-17 | — | — | EP | disclosed |
| US-4409232-A | HYPOTENSIVE AGENTS, ANTIARRHYTHMIA AGENTS | BEIERSDORF AKTIENGESELLSCHAFT (DE) | 1983-10-11 | — | — | US | disclosed |
| EP-0045955-B1 | ALKYL AND CYCLOALKYL SUBSTITUTED 2-(2-(2-HYDROXY-3-TERT.-BUTYLAMINO-PROPOXY)-5-ACYLAMINOPHENYL)-1,3,4-OXADIAZOLES, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | Beiersdorf Aktiengesellschaft (DE) | 1983-08-31 | — | — | EP | disclosed |
| EP-0045955-A1 | Alkyl and cycloalkyl substituted 2-(2-(2-hydroxy-3-tert.-butylamino-propoxy)-5-acylaminophenyl)-1,3,4-oxadiazoles, their preparation and pharmaceutical preparations containing them | Beiersdorf Aktiengesellschaft (DE) | 1982-02-17 | — | — | EP | disclosed |